nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—ABCC8—ATP sensitive Potassium channels—ABCC9—uterine cancer	0.134	0.275	CbGpPWpGaD
Tolazamide—KCNJ11—ATP sensitive Potassium channels—ABCC9—uterine cancer	0.13	0.266	CbGpPWpGaD
Tolazamide—KCNJ1—Inwardly rectifying K+ channels—ABCC9—uterine cancer	0.0509	0.104	CbGpPWpGaD
Tolazamide—ABCC8—Inwardly rectifying K+ channels—ABCC9—uterine cancer	0.026	0.0534	CbGpPWpGaD
Tolazamide—KCNJ11—Inwardly rectifying K+ channels—ABCC9—uterine cancer	0.0252	0.0517	CbGpPWpGaD
Tolazamide—ABCC8—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.0231	0.0473	CbGpPWpGaD
Tolazamide—Glyburide—ABCC9—uterine cancer	0.0229	0.609	CrCbGaD
Tolazamide—Digestion impaired—Progesterone—uterine cancer	0.0208	0.0438	CcSEcCtD
Tolazamide—KCNJ1—Potassium Channels—ABCC9—uterine cancer	0.0201	0.0412	CbGpPWpGaD
Tolazamide—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.0189	0.0397	CcSEcCtD
Tolazamide—Heartburn—Medroxyprogesterone Acetate—uterine cancer	0.0183	0.0386	CcSEcCtD
Tolazamide—Eruption—Dactinomycin—uterine cancer	0.016	0.0337	CcSEcCtD
Tolazamide—Jaundice cholestatic—Progesterone—uterine cancer	0.0158	0.0333	CcSEcCtD
Tolazamide—Gliclazide—VEGFA—uterine cancer	0.0147	0.391	CrCbGaD
Tolazamide—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.0143	0.0302	CcSEcCtD
Tolazamide—ABCC8—Potassium Channels—ABCC9—uterine cancer	0.0103	0.0211	CbGpPWpGaD
Tolazamide—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0213	CcSEcCtD
Tolazamide—KCNJ11—Potassium Channels—ABCC9—uterine cancer	0.00996	0.0204	CbGpPWpGaD
Tolazamide—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00938	0.0197	CcSEcCtD
Tolazamide—Aplastic anaemia—Dactinomycin—uterine cancer	0.00923	0.0194	CcSEcCtD
Tolazamide—Abdominal distension—Progesterone—uterine cancer	0.00879	0.0185	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—ABCC9—uterine cancer	0.00878	0.018	CbGpPWpGaD
Tolazamide—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.00796	0.0168	CcSEcCtD
Tolazamide—Eruption—Epirubicin—uterine cancer	0.00649	0.0137	CcSEcCtD
Tolazamide—Erythema—Progesterone—uterine cancer	0.00608	0.0128	CcSEcCtD
Tolazamide—Eruption—Doxorubicin—uterine cancer	0.006	0.0126	CcSEcCtD
Tolazamide—Pancytopenia—Dactinomycin—uterine cancer	0.00586	0.0123	CcSEcCtD
Tolazamide—Ill-defined disorder—Progesterone—uterine cancer	0.00564	0.0119	CcSEcCtD
Tolazamide—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00551	0.0116	CcSEcCtD
Tolazamide—Malaise—Progesterone—uterine cancer	0.00548	0.0116	CcSEcCtD
Tolazamide—Vertigo—Progesterone—uterine cancer	0.00546	0.0115	CcSEcCtD
Tolazamide—Agranulocytosis—Dactinomycin—uterine cancer	0.00513	0.0108	CcSEcCtD
Tolazamide—Discomfort—Progesterone—uterine cancer	0.00512	0.0108	CcSEcCtD
Tolazamide—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00511	0.0108	CcSEcCtD
Tolazamide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00497	0.0105	CcSEcCtD
Tolazamide—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00495	0.0104	CcSEcCtD
Tolazamide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00464	0.00976	CcSEcCtD
Tolazamide—Jaundice cholestatic—Epirubicin—uterine cancer	0.00454	0.00956	CcSEcCtD
Tolazamide—ABCC8—Neuronal System—ABCC9—uterine cancer	0.00449	0.0092	CbGpPWpGaD
Tolazamide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.0044	0.00927	CcSEcCtD
Tolazamide—Dyspepsia—Progesterone—uterine cancer	0.00437	0.0092	CcSEcCtD
Tolazamide—KCNJ11—Neuronal System—ABCC9—uterine cancer	0.00435	0.00892	CbGpPWpGaD
Tolazamide—ABCC8—Integration of energy metabolism—STK11—uterine cancer	0.00435	0.00892	CbGpPWpGaD
Tolazamide—Erythema—Dactinomycin—uterine cancer	0.0043	0.00905	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Progesterone—uterine cancer	0.00429	0.00903	CcSEcCtD
Tolazamide—Fatigue—Progesterone—uterine cancer	0.00428	0.00901	CcSEcCtD
Tolazamide—Pancytopenia—Etoposide—uterine cancer	0.00424	0.00893	CcSEcCtD
Tolazamide—KCNJ11—Integration of energy metabolism—STK11—uterine cancer	0.00422	0.00865	CbGpPWpGaD
Tolazamide—Jaundice cholestatic—Doxorubicin—uterine cancer	0.0042	0.00885	CcSEcCtD
Tolazamide—Feeling abnormal—Progesterone—uterine cancer	0.00409	0.00861	CcSEcCtD
Tolazamide—Ill-defined disorder—Dactinomycin—uterine cancer	0.00399	0.0084	CcSEcCtD
Tolazamide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00396	0.00834	CcSEcCtD
Tolazamide—Urticaria—Progesterone—uterine cancer	0.00394	0.0083	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00388	0.00818	CcSEcCtD
Tolazamide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00388	0.00817	CcSEcCtD
Tolazamide—Malaise—Dactinomycin—uterine cancer	0.00388	0.00816	CcSEcCtD
Tolazamide—Leukopenia—Dactinomycin—uterine cancer	0.00385	0.0081	CcSEcCtD
Tolazamide—Aplastic anaemia—Epirubicin—uterine cancer	0.00375	0.00789	CcSEcCtD
Tolazamide—Agranulocytosis—Etoposide—uterine cancer	0.00372	0.00782	CcSEcCtD
Tolazamide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00371	0.00781	CcSEcCtD
Tolazamide—Discomfort—Dactinomycin—uterine cancer	0.00362	0.00762	CcSEcCtD
Tolazamide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00357	0.00753	CcSEcCtD
Tolazamide—Asthenia—Progesterone—uterine cancer	0.00356	0.0075	CcSEcCtD
Tolazamide—Pruritus—Progesterone—uterine cancer	0.00351	0.0074	CcSEcCtD
Tolazamide—Aplastic anaemia—Doxorubicin—uterine cancer	0.00347	0.0073	CcSEcCtD
Tolazamide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00343	0.00723	CcSEcCtD
Tolazamide—Dizziness—Progesterone—uterine cancer	0.00328	0.00691	CcSEcCtD
Tolazamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00323	0.0068	CcSEcCtD
Tolazamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00318	0.0067	CcSEcCtD
Tolazamide—Rash—Progesterone—uterine cancer	0.00313	0.00659	CcSEcCtD
Tolazamide—Headache—Progesterone—uterine cancer	0.00311	0.00655	CcSEcCtD
Tolazamide—Fatigue—Dactinomycin—uterine cancer	0.00302	0.00637	CcSEcCtD
Tolazamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00297	0.00626	CcSEcCtD
Tolazamide—Hypoglycaemia—Epirubicin—uterine cancer	0.00297	0.00625	CcSEcCtD
Tolazamide—Nausea—Progesterone—uterine cancer	0.00295	0.00621	CcSEcCtD
Tolazamide—Hyponatraemia—Epirubicin—uterine cancer	0.00291	0.00612	CcSEcCtD
Tolazamide—Feeling abnormal—Dactinomycin—uterine cancer	0.00289	0.00609	CcSEcCtD
Tolazamide—Ill-defined disorder—Etoposide—uterine cancer	0.00289	0.00608	CcSEcCtD
Tolazamide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.00597	CcSEcCtD
Tolazamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00282	0.00593	CcSEcCtD
Tolazamide—Malaise—Etoposide—uterine cancer	0.00281	0.00591	CcSEcCtD
Tolazamide—Vertigo—Etoposide—uterine cancer	0.0028	0.00589	CcSEcCtD
Tolazamide—Leukopenia—Etoposide—uterine cancer	0.00278	0.00587	CcSEcCtD
Tolazamide—Hypoglycaemia—Doxorubicin—uterine cancer	0.00275	0.00578	CcSEcCtD
Tolazamide—Hyponatraemia—Doxorubicin—uterine cancer	0.00269	0.00567	CcSEcCtD
Tolazamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.00563	CcSEcCtD
Tolazamide—Discomfort—Etoposide—uterine cancer	0.00262	0.00551	CcSEcCtD
Tolazamide—Abdominal distension—Epirubicin—uterine cancer	0.00252	0.00531	CcSEcCtD
Tolazamide—Asthenia—Dactinomycin—uterine cancer	0.00252	0.0053	CcSEcCtD
Tolazamide—Thrombocytopenia—Etoposide—uterine cancer	0.00249	0.00524	CcSEcCtD
Tolazamide—ABCC8—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00241	0.00495	CbGpPWpGaD
Tolazamide—Pancytopenia—Epirubicin—uterine cancer	0.00238	0.00501	CcSEcCtD
Tolazamide—Abdominal distension—Doxorubicin—uterine cancer	0.00233	0.00491	CcSEcCtD
Tolazamide—Photosensitivity reaction—Epirubicin—uterine cancer	0.00228	0.00481	CcSEcCtD
Tolazamide—Rash—Dactinomycin—uterine cancer	0.00221	0.00466	CcSEcCtD
Tolazamide—Pancytopenia—Doxorubicin—uterine cancer	0.0022	0.00463	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.00219	0.00462	CcSEcCtD
Tolazamide—Fatigue—Etoposide—uterine cancer	0.00219	0.00461	CcSEcCtD
Tolazamide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00211	0.00445	CcSEcCtD
Tolazamide—Feeling abnormal—Etoposide—uterine cancer	0.00209	0.00441	CcSEcCtD
Tolazamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.00209	0.00428	CbGpPWpGaD
Tolazamide—Nausea—Dactinomycin—uterine cancer	0.00208	0.00439	CcSEcCtD
Tolazamide—Agranulocytosis—Epirubicin—uterine cancer	0.00208	0.00439	CcSEcCtD
Tolazamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.00202	0.00415	CbGpPWpGaD
Tolazamide—Urticaria—Etoposide—uterine cancer	0.00202	0.00425	CcSEcCtD
Tolazamide—Agranulocytosis—Doxorubicin—uterine cancer	0.00193	0.00406	CcSEcCtD
Tolazamide—Asthenia—Etoposide—uterine cancer	0.00182	0.00384	CcSEcCtD
Tolazamide—Pruritus—Etoposide—uterine cancer	0.0018	0.00378	CcSEcCtD
Tolazamide—Erythema—Epirubicin—uterine cancer	0.00174	0.00367	CcSEcCtD
Tolazamide—Dizziness—Etoposide—uterine cancer	0.00168	0.00354	CcSEcCtD
Tolazamide—Ill-defined disorder—Epirubicin—uterine cancer	0.00162	0.00341	CcSEcCtD
Tolazamide—Erythema—Doxorubicin—uterine cancer	0.00161	0.0034	CcSEcCtD
Tolazamide—Rash—Etoposide—uterine cancer	0.0016	0.00337	CcSEcCtD
Tolazamide—Headache—Etoposide—uterine cancer	0.00159	0.00335	CcSEcCtD
Tolazamide—Malaise—Epirubicin—uterine cancer	0.00157	0.00331	CcSEcCtD
Tolazamide—Vertigo—Epirubicin—uterine cancer	0.00157	0.0033	CcSEcCtD
Tolazamide—ABCC8—Metabolism—SRD5A2—uterine cancer	0.00156	0.0032	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—NDUFB11—uterine cancer	0.00156	0.0032	CbGpPWpGaD
Tolazamide—Leukopenia—Epirubicin—uterine cancer	0.00156	0.00329	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—NDUFB11—uterine cancer	0.00152	0.00311	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—SRD5A2—uterine cancer	0.00152	0.00311	CbGpPWpGaD
Tolazamide—Nausea—Etoposide—uterine cancer	0.00151	0.00318	CcSEcCtD
Tolazamide—Ill-defined disorder—Doxorubicin—uterine cancer	0.0015	0.00315	CcSEcCtD
Tolazamide—Discomfort—Epirubicin—uterine cancer	0.00147	0.00309	CcSEcCtD
Tolazamide—Malaise—Doxorubicin—uterine cancer	0.00146	0.00306	CcSEcCtD
Tolazamide—Vertigo—Doxorubicin—uterine cancer	0.00145	0.00305	CcSEcCtD
Tolazamide—Leukopenia—Doxorubicin—uterine cancer	0.00144	0.00304	CcSEcCtD
Tolazamide—Thrombocytopenia—Epirubicin—uterine cancer	0.00139	0.00294	CcSEcCtD
Tolazamide—Discomfort—Doxorubicin—uterine cancer	0.00136	0.00286	CcSEcCtD
Tolazamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.00129	0.00272	CcSEcCtD
Tolazamide—Dyspepsia—Epirubicin—uterine cancer	0.00125	0.00264	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00123	0.00259	CcSEcCtD
Tolazamide—Fatigue—Epirubicin—uterine cancer	0.00123	0.00258	CcSEcCtD
Tolazamide—Feeling abnormal—Epirubicin—uterine cancer	0.00117	0.00247	CcSEcCtD
Tolazamide—Dyspepsia—Doxorubicin—uterine cancer	0.00116	0.00244	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00114	0.00239	CcSEcCtD
Tolazamide—Fatigue—Doxorubicin—uterine cancer	0.00114	0.00239	CcSEcCtD
Tolazamide—Urticaria—Epirubicin—uterine cancer	0.00113	0.00238	CcSEcCtD
Tolazamide—ABCC8—Metabolism—AKR1B1—uterine cancer	0.00113	0.00232	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—STAR—uterine cancer	0.00113	0.00232	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AKR1B1—uterine cancer	0.0011	0.00225	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—STAR—uterine cancer	0.0011	0.00225	CbGpPWpGaD
Tolazamide—Feeling abnormal—Doxorubicin—uterine cancer	0.00109	0.00229	CcSEcCtD
Tolazamide—KCNJ1—Neuronal System—HRAS—uterine cancer	0.00105	0.00216	CbGpPWpGaD
Tolazamide—Urticaria—Doxorubicin—uterine cancer	0.00105	0.0022	CcSEcCtD
Tolazamide—Asthenia—Epirubicin—uterine cancer	0.00102	0.00215	CcSEcCtD
Tolazamide—Pruritus—Epirubicin—uterine cancer	0.00101	0.00212	CcSEcCtD
Tolazamide—Asthenia—Doxorubicin—uterine cancer	0.000945	0.00199	CcSEcCtD
Tolazamide—Dizziness—Epirubicin—uterine cancer	0.000941	0.00198	CcSEcCtD
Tolazamide—Pruritus—Doxorubicin—uterine cancer	0.000932	0.00196	CcSEcCtD
Tolazamide—Rash—Epirubicin—uterine cancer	0.000897	0.00189	CcSEcCtD
Tolazamide—Headache—Epirubicin—uterine cancer	0.000892	0.00188	CcSEcCtD
Tolazamide—ABCC8—Metabolism—POLD1—uterine cancer	0.000886	0.00182	CbGpPWpGaD
Tolazamide—Dizziness—Doxorubicin—uterine cancer	0.000871	0.00183	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—POLD1—uterine cancer	0.00086	0.00176	CbGpPWpGaD
Tolazamide—Nausea—Epirubicin—uterine cancer	0.000845	0.00178	CcSEcCtD
Tolazamide—Rash—Doxorubicin—uterine cancer	0.00083	0.00175	CcSEcCtD
Tolazamide—ABCC8—Metabolism—AKR1C1—uterine cancer	0.000829	0.0017	CbGpPWpGaD
Tolazamide—Headache—Doxorubicin—uterine cancer	0.000825	0.00174	CcSEcCtD
Tolazamide—KCNJ11—Metabolism—AKR1C1—uterine cancer	0.000804	0.00165	CbGpPWpGaD
Tolazamide—Nausea—Doxorubicin—uterine cancer	0.000782	0.00165	CcSEcCtD
Tolazamide—ABCC8—Metabolism—RRM2—uterine cancer	0.000739	0.00152	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—DCN—uterine cancer	0.000717	0.00147	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—RRM2—uterine cancer	0.000717	0.00147	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—DCN—uterine cancer	0.000696	0.00143	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP11A1—uterine cancer	0.000676	0.00139	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP11A1—uterine cancer	0.000655	0.00134	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AKR1C3—uterine cancer	0.000638	0.00131	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AKR1C3—uterine cancer	0.000619	0.00127	CbGpPWpGaD
Tolazamide—ABCC8—Neuronal System—HRAS—uterine cancer	0.000539	0.00111	CbGpPWpGaD
Tolazamide—KCNJ11—Neuronal System—HRAS—uterine cancer	0.000522	0.00107	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—STK11—uterine cancer	0.000497	0.00102	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—CYP19A1—uterine cancer	0.000497	0.00102	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—CYP19A1—uterine cancer	0.000482	0.000989	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—STK11—uterine cancer	0.000482	0.000989	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—MTHFR—uterine cancer	0.000374	0.000766	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—MTHFR—uterine cancer	0.000362	0.000743	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PTEN—uterine cancer	0.000208	0.000426	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PTEN—uterine cancer	0.000202	0.000413	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—EP300—uterine cancer	0.000198	0.000407	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—EP300—uterine cancer	0.000192	0.000394	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—PIK3CA—uterine cancer	0.000147	0.000301	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—PIK3CA—uterine cancer	0.000142	0.000292	CbGpPWpGaD
Tolazamide—ABCC8—Metabolism—AKT1—uterine cancer	0.00012	0.000246	CbGpPWpGaD
Tolazamide—KCNJ11—Metabolism—AKT1—uterine cancer	0.000116	0.000238	CbGpPWpGaD
